In this post in the U.S. Department of State’s “DipNote” blog, U.S. Global AIDS Coordinator Ambassador Eric Goosby and Melanne Verveer, ambassador-at-large for global women’s issues, report on the relationship between gender-based violence (GBV) and HIV, writing, “The United States recognizes the importance of preventing and responding to GBV within…
The 16th International Conference on AIDS and Sexually Transmitted Infections in Africa (ICASA) ended on Thursday in Addis Ababa, Ethiopia, where “the final plenary session … left the audience with a notion of hope and urgency that despite the Global Fund’s cancellation of Round 11 disbursements, the organization will continue to campaign, raise funds and place pressure on governments in both the donor and recipient arenas,” an ICASA news article reports (12/8). Speaking at the session, “Global Fund Deputy Executive Director Debrework Zewdie felt compelled to reassure those benefiting from the fund,” saying, “‘Everyone who is on treatment funded by the Global Fund will stay on treatment,'” according to Deutsche Presse-Agentur/M&C (Frentzen/Waswa, 12/8).
In this post in the Global Network for Neglected Tropical Diseases’ (NTDs) “End the Neglect” blog, Julien Potet, NTD policy adviser at Medecins Sans Frontieres’ Campaign for Access to Essential Medicines, examines the treatment of visceral leishmaniasis among people living with HIV in East Africa. He writes, “With new and…
Daniela Ligiero of the State Department, Sasha Mital of the CDC, and Diana Prieto of USAID, who are co-chairs of the PEPFAR Gender Technical Working Group, write about the “intersection between gender-based violence (GBV) and its impact on HIV risk and access to HIV prevention and treatment for most-at-risk populations…
Science examines recent successes in clinical trials in the HIV prevention field, limitations to mathematical models resulting from these trials, and funding issues facing campaigns to ramp up HIV prevention interventions. “[M]odels now suggest that combining [prevention strategies] might virtually stop HIV’s spread,” but “there’s a vast difference between a study having success and thwarting HIV in the real world,” according to Science. “Models only point out routes to ending AIDS, and many will surely differ,” the magazine writes, concluding, “But for the first time since AIDS surfaced 31 years ago, many researchers believe the destination itself is no longer a mirage” (Cohen, 12/9).
“The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems,” IIP Digital reports. “More than 720,000 Basotho are expected to benefit from the MCC health project over the next 20 years,” the news service writes.
In this Toronto Star opinion piece, Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, and Nicci Stein, executive director of the Interagency Coalition on AIDS and Development, discuss how progress made in the fight against HIV/AIDS over the last 30 years “is in peril, due to governments reneging on repeated promises to fund the fight against the pandemic.”
“[S]topping the AIDS pandemic requires sustained engagement from both donor and developing countries, political commitments that are backed by dollars. … Yet many donor countries have chosen precisely this moment to abandon their promises,” they write. They discuss the cancellation of Round 11 grants by the Global Fund to Fight AIDS, Tuberculosis and Malaria, and ask the Canadian government to deliver on its HIV/AIDS funding pledges. Elliott and Stein conclude, “We can turn the tide on the spread of HIV — victory has never been closer. But we need to make sure that those with the power and the money use it toward achieving the goal of an end to AIDS” (12/7).
Babatunde Osotimehin, executive director of the United Nations Population Fund (UNFPA) and under-secretary-general of the U.N., answers questions about his work from Forbes contributor Rahim Kanani in this interview excerpt. Osotimehin “discussed current trends in population growth, innovative approaches to tackling HIV/AIDS, leadership lessons in public health, challenges to safeguarding maternal health while encouraging family planning, and much more,” according to Forbes (12/8).
In this Foreign Affairs opinion piece, Mead Over, a senior fellow at the Center for Global Development, says the goal of an “AIDS-free generation” is attainable, “[b]ut not if treatment continues to take precedence over prevention.” He continues, “It is unfortunate that so many have focused on treatment alone because there is a way to end the global scourge of HIV/AIDS: by conditioning the rate of expansion of treatment programs on the reduction of new infections. This much-needed shift would lead to what I call an AIDS transition — the day on which the rate of new infections falls below the rate of AIDS-related deaths so that the number of people living with HIV/AIDS decreases year-on-year.”
“A group that tracks funding for neglected diseases released its fourth annual report Wednesday, showing for the first time since 2007 a decrease in government and public spending in global health research and development,” the Center for Global Health Policy’s “Science Speaks” blog reports (Mazzotta, 12/7). The Global Funding of Innovation for Neglected Diseases (G-FINDER) survey report, conducted by Policy Cures and funded by the Bill & Melinda Gates Foundation, found that “[p]ublic funding from the world’s richest nations for research and development (R&D) of new neglected disease products fell by US$125 million (down six percent) in 2010,” a Policy Cures press release (.pdf) states (12/7).